Editorial overview: The march of mucosal vaccines
Current Opinion in Immunology · 2024
DOI: 10.1016/j.coi.2023.102408 ↗Kurz gefasst
Editorial in der Zeitschrift Current Opinion in Immunology, 2024. Verfasst von E C Lavelle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
- Infectious Diseases Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: meritxell.genesca@vhir.org.
Zitieren
APA
Lavelle, E. C., & Genescà, M. (2024). Editorial overview: The march of mucosal vaccines. Current Opinion in Immunology. https://doi.org/10.1016/j.coi.2023.102408
Vancouver
Lavelle EC, Genescà M. Editorial overview: The march of mucosal vaccines. Current Opinion in Immunology. 2024. doi:10.1016/j.coi.2023.102408
BibTeX
@article{Lavelle2024,
author = {Lavelle, E C and Genescà, Meritxell},
title = {Editorial overview: The march of mucosal vaccines},
journal = {Current Opinion in Immunology},
year = {2024},
doi = {10.1016/j.coi.2023.102408}
}
EUVIMED